Comparing HGSC with CCC highlighted the enriched expression of specific proteins previously described for ovarian carcinoma, such as: HNF-1β, NID2, NAPSA, and CRYAB for CCC, and CRABP2, TP53, and WT1 for HGSC (Fig. 1b)26. This evidence concerns the gene NID2 and ovarian carcinoma.